All 258 BIB (PROSHARES ULTRA NASDAQ BIOTECHNOLOGY) Holdings
There are 258 BIB holdings. Top 10 companies weight: 60.91%.
Total Market Cap: $1.73T
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (258 stocks) | +18.25% | 21.12 | 15.77 | 0.45 | +26.32% | +9.60% | 0.75 | ||||||||||
101 | NTLA | Intellia Therapeutics Inc | 0.09% | $11.47 | $1.57B | Biotechnology | Healthcare | +8.10% | N/A | N/A | N/A | N/A | N/A | 62 | +128.16% | $26 | -40.03% | 1.78 |
102 | VCEL | Vericel Corp | 0.09% | $46.14 | $2.38B | Biotechnology | Healthcare | +35.66% | 109.92 | 98.04 | 0.18 | N/A | N/A | 71 | +23.84% | $57 | -2.68% | 1.13 |
103 | PHVS | Pharvaris Nv Ordinary Shares | 0.09% | $34.45 | $2.30B | Biotechnology | Healthcare | +9.20% | N/A | N/A | N/A | N/A | N/A | 78 | +37.10% | $47 | +18.99% | 0.66 |
104 | MLYS | Mineralys Therapeutics Inc | 0.09% | $27.52 | $2.43B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 72 | +78.05% | $49 | 0.00% | 0.77 |
105 | KOD | Kodiak Sciences Inc | 0.09% | $42.42 | $2.64B | Biotechnology | Healthcare | +4.23% | N/A | N/A | N/A | N/A | N/A | 78 | +47.74% | $63 | -12.93% | 1.69 |
106 | AGIO | Agios Pharmaceuticals Inc | 0.09% | $37.36 | $2.37B | Biotechnology | Healthcare | N/A | N/A | 2.47 | N/A | N/A | N/A | 67 | +14.08% | $43 | -6.09% | 1.01 |
107 | STOK | Stoke Therapeutics Inc | 0.08% | $28.81 | $1.86B | Biotechnology | Healthcare | +11.95% | N/A | 204.08 | N/A | N/A | N/A | 77 | +59.04% | $46 | -1.54% | 1.05 |
108 | GLUE | Monte Rosa Therapeutics Inc | 0.08% | $23.63 | $1.97B | Biotechnology | Healthcare | N/A | N/A | 10.02 | N/A | N/A | N/A | 81 | +40.37% | $33 | +1.29% | 1.31 |
109 | SRPT | Sarepta Therapeutics Inc | 0.08% | $16.21 | $1.86B | Biotechnology | Healthcare | N/A | 4.88 | 5.76 | 159.25 | N/A | N/A | 48 | +36.77% | $22 | -25.17% | 1.40 |
110 | HRMY | N/A | 0.08% | $36.84 | $2.02B | Biotechnology | Healthcare | N/A | 13.82 | 10.71 | N/A | N/A | N/A | 63 | +21.91% | $45 | +4.64% | 0.63 |
111 | AMLX | Amylyx Pharmaceuticals Inc | 0.08% | $18.50 | $1.97B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | N/A | 2.77 | N/A | N/A | N/A | 72 | +33.51% | $25 | 0.00% | 1.14 |
112 | ADMA | Adma Biologics Inc | 0.08% | $8.59 | $2.02B | Biotechnology | Healthcare | N/A | 12.42 | 10.50 | N/A | N/A | N/A | 75 | +97.90% | $17 | +40.30% | 1.16 |
113 | OCUL | Ocular Therapeutix Inc | 0.08% | $8.93 | $2.18B | Biotechnology | Healthcare | -4.26% | N/A | N/A | N/A | N/A | N/A | 84 | +203.36% | $27 | -5.93% | 1.29 |
114 | RXRX | Recursion Pharmaceuticals Inc Class A | 0.08% | $3.08 | $1.76B | Biotechnology | Healthcare | -10.03% | N/A | N/A | N/A | N/A | N/A | 65 | +135.39% | $7.25 | -38.84% | 2.63 |
115 | AUPH | Aurinia Pharmaceuticals Inc | 0.08% | $15.64 | $2.11B | Biotechnology | Healthcare | N/A | 9.58 | 18.38 | 0.02 | N/A | N/A | 64 | +8.70% | $17 | +6.21% | 0.72 |
116 | GMAB | Genmab As Adr | 0.08% | $28.37 | $19B | Biotechnology | Healthcare | -30.81% | 140.29 | 16.95 | 1.91 | N/A | N/A | 70 | +30.16% | $37 | -8.56% | 0.59 |
117 | ZYME | Zymeworks Inc Registered Shs | 0.07% | $24.05 | $1.80B | Biotechnology | Healthcare | N/A | N/A | 23.75 | N/A | N/A | N/A | 79 | +63.53% | $39 | -7.81% | 0.83 |
118 | SNDX | Syndax Pharmaceuticals Inc | 0.07% | $22.64 | $2.08B | Biotechnology | Healthcare | +12.13% | N/A | N/A | N/A | N/A | N/A | 78 | +72.26% | $39 | +9.02% | 1.03 |
119 | TSHA | N/A | 0.07% | $5.67 | $1.78B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 80 | +129.28% | $13 | -21.91% | 1.42 |
120 | PGEN | Precigen Inc | 0.07% | $5.49 | $1.82B | Biotechnology | Healthcare | -3.91% | N/A | 250.00 | N/A | N/A | N/A | 75 | +126.78% | $12 | -0.25% | 1.67 |
121 | NVCR | Novocure Ltd | 0.07% | $16 | $1.86B | Medical Devices | Healthcare | N/A | N/A | 909.09 | N/A | N/A | N/A | 71 | +55.50% | $25 | -39.03% | 1.37 |
122 | FTRE | Fortrea Holdings Inc | 0.07% | $17.91 | $1.69B | Biotechnology | Healthcare | N/A | N/A | 13.87 | 0.34 | N/A | N/A | 52 | -3.69% | $17 | 0.00% | 1.87 |
123 | CMPS | Compass Pathways Plc Adr | 0.07% | $12.18 | $1.80B | Medical Care Facilities | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 78 | +100.90% | $24 | -19.88% | 1.38 |
124 | RAPP | Rapport Therapeutics Inc | 0.07% | $42.56 | $1.91B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +33.08% | $57 | 0.00% | 1.27 |
125 | SION | Sionna Therapeutics Inc | 0.07% | $47.21 | $2B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 68 | +9.30% | $52 | 0.00% | 0.90 |
126 | BCAX | Bicara Therapeutics Inc | 0.07% | $28.15 | $1.84B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.00% | N/A |
127 | ATAI | Ataibeckley Inc | 0.07% | $7.14 | $1.96B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -16.19% | N/A |
128 | ZBIO | Zenas Biopharma Inc | 0.07% | $32.36 | $1.83B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 71 | +30.16% | $42 | 0.00% | 1.25 |
129 | GHRS | Gh Research Plc | 0.07% | $28.35 | $1.67B | Biotechnology | Healthcare | +89.13% | N/A | N/A | N/A | N/A | N/A | 83 | +39.33% | $40 | +9.51% | 0.92 |
130 | IOVA | Iovance Biotherapeutics Inc | 0.07% | $5.48 | $2.08B | Biotechnology | Healthcare | -12.60% | N/A | N/A | N/A | N/A | N/A | 75 | +60.58% | $8.80 | -25.11% | 1.60 |
131 | TYRA | Tyra Biosciences Inc | 0.07% | $31.85 | $1.93B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 76 | +63.17% | $52 | 0.00% | 1.02 |
132 | n/a | Urogen Pharma Ltd | 0.07% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
133 | ANIP | Ani Pharmaceuticals Inc | 0.07% | $79.15 | $1.69B | Drug Manufacturers - Specialty & Generic | Healthcare | +25.74% | 20.37 | 9.59 | 0.01 | N/A | N/A | 85 | +38.98% | $110 | +18.93% | 0.60 |
134 | ANAB | Anaptysbio Inc | 0.07% | $53.76 | $1.62B | Biotechnology | Healthcare | -4.15% | N/A | N/A | N/A | N/A | N/A | 81 | +62.00% | $87 | +25.59% | 0.81 |
135 | ABSI | Absci Corp | 0.07% | $8.32 | $1.49B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +65.62% | $14 | -17.36% | 2.33 |
136 | VIR | Vir Biotechnology Inc | 0.06% | $9.42 | $1.55B | Biotechnology | Healthcare | -0.01% | N/A | 4.27 | N/A | N/A | N/A | 82 | +128.87% | $22 | -24.08% | 1.52 |
137 | IMCR | Immunocore Holdings Plc Adr | 0.06% | $34.48 | $1.76B | Biotechnology | Healthcare | N/A | N/A | 232.56 | N/A | N/A | N/A | 69 | +83.79% | $63 | -0.13% | 0.70 |
138 | HROW | Harrow Inc | 0.06% | $43.71 | $1.60B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | N/A | 312.50 | N/A | N/A | N/A | 75 | +55.00% | $68 | +41.16% | 1.72 |
139 | MAZE | Maze Therapeutics Inc | 0.06% | $29.30 | $1.46B | Biotechnology | Healthcare | N/A | N/A | 8.53 | N/A | N/A | N/A | 77 | +113.48% | $63 | 0.00% | 0.87 |
140 | INVA | Innoviva Inc | 0.06% | $21.58 | $1.62B | Biotechnology | Healthcare | +16.74% | 3.15 | 11.07 | 0.32 | N/A | N/A | 62 | +64.50% | $36 | +9.98% | 0.16 |
141 | PSNL | Personalis Inc | 0.06% | $13.44 | $1.65B | Diagnostics & Research | Healthcare | -3.14% | N/A | N/A | N/A | N/A | N/A | 75 | -1.12% | $13 | -9.37% | 2.30 |
142 | NVAX | Novavax Inc | 0.06% | $8.07 | $1.39B | Biotechnology | Healthcare | -42.97% | N/A | 2.59 | 1.32 | N/A | N/A | 50 | +74.74% | $14 | -47.88% | 1.45 |
143 | AVBP | Arrivent Biopharma Inc | 0.06% | $28.26 | $1.49B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.00% | N/A |
144 | SEPN | Septerna Inc | 0.06% | $33.68 | $1.53B | Biotechnology | Healthcare | N/A | N/A | 107.53 | N/A | N/A | N/A | 77 | +33.61% | $45 | 0.00% | 1.24 |
145 | MGTX | Meiragtx Holdings Plc | 0.05% | $12.52 | $1.02B | Biotechnology | Healthcare | -1.60% | N/A | 1.62 | N/A | N/A | N/A | 81 | +126.68% | $28 | -3.01% | 1.29 |
146 | MNKD | Mannkind Corp | 0.05% | $4.05 | $1.26B | Biotechnology | Healthcare | -21.18% | N/A | 42.37 | 4.39 | N/A | N/A | 71 | +87.41% | $7.59 | -2.00% | 0.71 |
147 | ARDX | Ardelyx Inc | 0.05% | $5.09 | $1.31B | Biotechnology | Healthcare | -26.76% | N/A | 40.65 | N/A | N/A | N/A | N/A | N/A | N/A | +23.52% | N/A |
148 | COLL | Collegium Pharmaceutical Inc | 0.05% | $35.85 | $1.19B | Drug Manufacturers - Specialty & Generic | Healthcare | -5.45% | 40.29 | 4.86 | N/A | N/A | N/A | 79 | +49.51% | $54 | +7.73% | 0.50 |
149 | SVRA | Savara Inc | 0.05% | $5.84 | $1.19B | Biotechnology | Healthcare | -2.12% | N/A | 0.41 | N/A | N/A | N/A | 81 | +87.33% | $11 | +33.84% | 1.22 |
150 | CRVS | Corvus Pharmaceuticals Inc | 0.05% | $14.47 | $1.25B | Biotechnology | Healthcare | +53.96% | N/A | N/A | N/A | N/A | N/A | 78 | +130.34% | $33 | +43.84% | 0.76 |
BIB (PROSHARES ULTRA NASDAQ BIOTECHNOLOGY) Sector Allocation
HEALTHCARE
53.00%INFORMATION TECHNOLOGY
0.00%COMMUNICATION SERVICES
0.00%CONSUMER DISCRETIONARY
0.00%CONSUMER STAPLES
0.00%INDUSTRIALS
0.00%MATERIALS
0.00%UTILITIES
0.00%ENERGY
0.00%FINANCIALS
0.00%REAL ESTATE
0.00%